Category:

Leading up to NACDS Total Store Expo, Drug Store News had an opportunity to sit down with Tom O’Donnell, VP federal government affairs at the National Association of Chain Drug Stores, to discuss pharmacist provider status and the latest pro-pharmacy legislative initiatives in the U.S. House and Senate.

A telehealth program that engages patients before and after their hip and knee replacement procedures not only made those patients feel better about the experience and their providers, but reduced length of stay and improved post-discharge responses… VOX Telehealth… attribute… improvement to the fact that patients are more prepared for the process, so there are fewer complications or concerns that would merit a longer stay of(or) transfer to another facility...

Russia’s largest retail pharmacy chains improves profits by tapping into their big data with price optimization… -- Revionics, Inc.,a provider of optimization solutions, and distribution partner SmartService Ltd, announced…that they have entered into a multi-year agreement…with A5 Pharmacy Ltd., one of Russia’s largest pharmacy retail chains, which operates more than 700 retail locations throughout Russia.

To cure Maddie’s strep throat in time for her birthday party, all the little girl needs is some medicine and encouragement from her pharmacist in the children’s book Maddie Visits the Pharmacist… Author Donna Keissami, PharmD …life-long dream to write a children’s story. She was …inspired to write the story so that she could read it to her 2-year-old son..

Banner Health,..has expanded rapidly through acquisitions, is seeing its expenses outpace the additional revenue…Banner took over operations of the University of Arizona Health Network in February,…about $1 billion in funding and capital commitments… the short term, costs are rising. Banner reported an operating surplus of $107.6 million on $3.4 billion in revenue for the first half of the year…operating margin was 3.2%, compared with the prior year period's 7% margin...

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses counseling points for patients taking oral non-insulin diabetes medication (video)

Explosions last week at a warehouse in Tianjin, China hit a GSK drug manufacturing plant, It did not reveal which drug products are affected. GSK has two businesses in ...area: Sino-American Tianjin Smith Kline & French Laboratories Ltd., and GSK (Tianjin) Co. Ltd., both pharmaceutical joint ventures with local companies. GSK’s two Tianjin businesses will jointly donate 1m RMB ($156,000) cash to the Red Cross to help the emergency response. The firm said it is "on standby" to provide essential medicines.

Despite digital health's record breaking…growth last year – more recent reports showing it hasn't slowed down…more than half of all digital health startups are likely to fail..those fledgling companies that raked in a record $4.1 billion for 2014. Rather than discard the investment…in getting sputtering start-ups off the ground, it often makes sense for healthcare stakeholders to acquire them, salvage their best people and technologies…Many digital start-ups that are dying or in danger of failure have developed solutions that can help traditional and non-traditional healthcare companies achieve their goals..

Danish drugmaker, Lundbeck has announced plans to slash 1,000 jobs as part of a massive restructuring…to save 3bn Danish Krone ($444m) in costs…and cutting early pipelines ..unnamed early-stage drug programs, and focus on existing products Abilify Maintena, (aripiprazole), Brintellix (vortioxetine), Northera (droxidopa), Onfi (clobazam), and Rexulti (brexpiprazole)… also plans to expand its new business service center in Krakow,Poland…restructure operations at its headquarters in Valby, Denmark

AbbVie Inc has bought a (FDA) priority review voucher from United Therapeutics Corp for $350 million that will allow it to accelerate the review process for one of its drugs…pediatric disease priority review voucher…eligible to have one of its drugs reviewed in six months, compared to the standard 10 months...AbbVie did not disclose its plans for the voucher...